Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
RESEARCH TOOLSreports
Iovance Biotherapeutics (IOVA) Ownership - Who Owns Iovance Biotherapeutics?
2,392 Followers
Iovance Biotherapeutics (IOVA) Ownership Overview
12.60% Insiders
16.03% Mutual Funds
47.62% Other Institutional Investors
23.74% Public Companies and Individual Investors
The ownership structure of Iovance Biotherapeutics (IOVA) stock is a mix of institutional, retail and individual investors. Approximately 63.65% of the company’s stock is owned by Institutional Investors, 12.60% is owned by Insiders and 23.74% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 20, 2024 | Iain D. Dukes Director | Bought | $292800 |
| Feb 20, 2024 | Wayne P. Rothbaum Director | Bought | $45750000 |
| Feb 20, 2024 | Merrill A Mcpeak Director | Bought | $2287500 |
| Sep 19, 2023 | Merrill A Mcpeak Director | Bought | $55600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $4569060 | |
| Dec 31, 2023 | Bought | $13046259 | |
| Dec 31, 2023 | Bought | $97392643 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 24,243,492 | Institution | 8.68% | 328,014,447 | |
| 20,234,280 | Institution | 7.24% | 273,769,808 | |
| 11,979,415 | Institution | 4.29% | 162,081,485 | |
| 10,786,629 | Institution | 3.86% | 145,943,090 | |
| 5,210,750 | Institution | 1.87% | 70,501,448 | |
| 2,823,333 | Insider | 1.01% | 38,199,695 | |
| 2,545,427 | Institution | 0.91% | 34,439,627 | |
| 2,524,421 | Institution | 0.90% | 34,155,416 | |
| 2,109,760 | Institution | 0.76% | 28,545,053 | |
| 1,604,706 | Institution | 0.57% | 21,711,672 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,234,280 | Institution | 7.24% | 273,769,808 | |
| 2,545,427 | Institution | 0.91% | 34,439,627 | |
| 2,524,421 | Institution | 0.90% | 34,155,416 | |
| 2,109,760 | Institution | 0.76% | 28,545,053 | |
| 1,489,682 | Institution | 0.53% | 20,155,397 | |
| 1,482,277 | Institution | 0.53% | 20,055,208 | |
| 1,117,328 | Institution | 0.40% | 15,117,448 | |
| 1,096,198 | Institution | 0.39% | 14,831,559 | |
| 994,366 | Institution | 0.36% | 13,453,772 | |
| 908,758 | Institution | 0.33% | 12,295,496 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,873,458 | Institution | 2.82% | 125,266,717 | |
| 6,470,878 | Institution | 2.32% | 102,951,669 | |
| 5,779,344 | Institution | 2.07% | 78,599,078 | |
| 4,416,734 | Institution | 1.58% | 70,270,238 | |
| 4,763,584 | Institution | 1.71% | 64,784,742 | |
| 3,585,795 | Institution | 1.28% | 57,049,998 | |
| 2,230,498 | Institution | 0.80% | 30,334,773 | |
| 1,602,724 | Institution | 0.57% | 21,684,856 | |
| 1,143,979 | Institution | 0.41% | 15,558,114 | |
| 834,198 | Institution | 0.30% | 13,272,090 |
FAQ
Who Owns Iovance Biotherapeutics Inc (IOVA)?
According to the latest TipRanks data, approximately 47.62% of the company's stock is held by institutional investors, 12.60% is held by insiders, and 23.74% is held by retail investors.
What percentage of Iovance Biotherapeutics Inc (IOVA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 47.62% of Iovance Biotherapeutics Inc (IOVA) stock is held by institutional investors.
What percentage of Iovance Biotherapeutics Inc (IOVA) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.74% of Iovance Biotherapeutics Inc (IOVA) stock is held by retail investors.
Who owns the most shares of Iovance Biotherapeutics Inc (IOVA)?
Vanguard owns the most shares of Iovance Biotherapeutics Inc (IOVA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.